32 related articles for article (PubMed ID: 3353874)
21. [Effect of supplemental oxygen on exercise performance in patients with chronic obstructive pulmonary disease and an arterial oxygen tension over 60 Torr].
Ishimine A; Saito H; Nishimura M; Nakano T; Miyamoto K; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 May; 33(5):510-9. PubMed ID: 7609336
[TBL] [Abstract][Full Text] [Related]
22. Effects of supplemental oxygen during activity in patients with advanced COPD without severe resting hypoxemia.
Jolly EC; Di Boscio V; Aguirre L; Luna CM; Berensztein S; Gené RJ
Chest; 2001 Aug; 120(2):437-43. PubMed ID: 11502641
[TBL] [Abstract][Full Text] [Related]
23. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia.
McDonald CF; Blyth CM; Lazarus MD; Marschner I; Barter CE
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1616-9. PubMed ID: 7582304
[TBL] [Abstract][Full Text] [Related]
24. A reservoir nasal cannula improves protection given by oxygen during muscular exercise in COPD.
Arlati S; Rolo J; Micallef E; Sacerdoti C; Brambilla I
Chest; 1988 Jun; 93(6):1165-9. PubMed ID: 3371094
[TBL] [Abstract][Full Text] [Related]
25. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
Mak VH; Bugler JR; Roberts CM; Spiro SG
Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
[TBL] [Abstract][Full Text] [Related]
26. Ventilatory muscle function during exercise in air and oxygen in patients with chronic air-flow limitation.
Bye PT; Esau SA; Levy RD; Shiner RJ; Macklem PT; Martin JG; Pardy RL
Am Rev Respir Dis; 1985 Aug; 132(2):236-40. PubMed ID: 4026048
[TBL] [Abstract][Full Text] [Related]
27. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale.
Leggett RJ; Flenley DC
Br Med J; 1977 Jul; 2(6079):84-6. PubMed ID: 871805
[TBL] [Abstract][Full Text] [Related]
28. Effects of breathing supplemental oxygen before progressive exercise in patients with chronic obstructive lung disease.
McKeon JL; Murree-Allen K; Saunders NA
Thorax; 1988 Jan; 43(1):53-6. PubMed ID: 3353874
[TBL] [Abstract][Full Text] [Related]
29. Why treatment efficacy on breathlessness in laboratory but not daily life trials? The importance of standardized exertion.
Ekström M
Curr Opin Support Palliat Care; 2019 Sep; 13(3):179-183. PubMed ID: 31246594
[TBL] [Abstract][Full Text] [Related]
30. Supplemental oxygen for the management of dyspnea in interstitial lung disease.
Schaeffer MR; Molgat-Seon Y; Ryerson CJ; Guenette JA
Curr Opin Support Palliat Care; 2019 Sep; 13(3):174-178. PubMed ID: 31145136
[TBL] [Abstract][Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
